Cerevel Therapeutics Holdings News, Cerevel Therapeutics Holdings Quote, CERE Quote

Cerevel Therapeutics Holdings (NQ:CERE) Delayed: 42.14 --0 (-0%)

Prev. Close

$42.14

Open

$42.14

52 Wk High

$4.80

52 Wk Low

$0.16

Day High

$42.14

Day Low

$42.14

P/E

N/A

EPS

$-1.36

Volume

160

Friends, Peers and Foes (?): ABBV, GME, DG, NVDA, GOOGL (more...)

Apr 18, 2024 06:30 AM Cerevel Therapeutics Holdings (CERE) Reports Positive Topline Results for Tavapadon
Apr 18, 2024 06:30 AM Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Apr 11, 2024 03:32 PM Cerevel Therapeutics Holdings (CERE) call put ratio 1 call to 5.5 puts with focus on August 35 and 40 puts
Apr 3, 2024 04:15 PM Form 4 Cerevel Therapeutics For: Apr 01 Filed by: COLES N ANTHONY
Apr 1, 2024 04:33 PM Form 144 Cerevel Therapeutics Filed by: COLES N ANTHONY
Mar 4, 2024 05:50 PM Form 4 Cerevel Therapeutics For: Feb 29 Filed by: COLES N ANTHONY
Mar 4, 2024 05:37 PM Form 144 Cerevel Therapeutics Filed by: COLES N ANTHONY
Feb 29, 2024 04:23 PM Form 144 Cerevel Therapeutics Filed by: COLES N ANTHONY
Feb 27, 2024 04:03 PM Form 10-K Cerevel Therapeutics For: Dec 31
Feb 21, 2024 04:57 PM Form 4 Cerevel Therapeutics For: Feb 20 Filed by: PERCEPTIVE ADVISORS LLC

Entities mentioned with CERE